Browsing by Author Liberopoulos, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 46  next >
TitleAuthor(s)Issue date???itemlist.???
Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized StudyKei, A.; Elisaf, M. S.; Moutzouri, E.; Tsiara, S.; Liberopoulos, E.24-Nov-2015-
Alterations in paraoxonase (PON1) activity in patients with chronic kidney disease (CKD)Liberopoulos, E.; Papavasiliou, E.; Miltiadous, G.; Katopodis, K.; Pappas, M.; Tselepis, A.; Elisaf, M.; SIamopoulos, K.24-Nov-2015-
Alterations of serum paraoxonase I (PON1) and serum and HDL-associated platelet-activating-factor acetylhydrolase (PAF-AH) activities during haemodialysisLiberopoulos, E.; Papavasiliou, E.; Tselepis, A.; Siamopoulos, K.; Elisaf, M.24-Nov-2015-
Alterations of total serum and high-density lipoprotein (HDL)-related lipoprotein-associated phospholipase A2 (LpA2) in patients with chronic kidney disease (CKD)Liberopoulos, E.; Papavasiliou, E.; Andrikos, E.; Sferopoulos, G.; Elisaf, M.; Tselepis, A.; Siamopoulos, K.24-Nov-2015-
Aminoglycoside-induced reversible tubular dysfunctionAlexandridis, G.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015-
Anticoagulant drugs: what is new?Kei, A.; Florentin, M.; Elisaf, M. S.; Liberopoulos, E.24-Nov-2015-
The apolipoprotein B/apolipoprotein A1 ratio in metabolic syndromeGazi, I.; Tzovaras, V.; Liberopoulos, E.; Tsouli, S.; Spyrou, A.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Apolipoprotein E and renal diseaseLiberopoulos, E.; Siamopoulos, K.; Elisaf, M. S.24-Nov-2015-
Apolipoprotein E polymorphism in northwestern Greece: frequency and effect on lipid parametersLiberopoulos, E.; Miltiadous, G.; Hatzivassiliou, M.; Ayrton, N.; Bairaktari, E.; Cariolou, M.; Elisaf, M. S.24-Nov-2015-
Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?Liberopoulos, E.; Karabina, S. A.; Tselepis, A.; Bairaktari, E.; Nicolaides, C.; Pavlidis, N.; Elisaf, M.24-Nov-2015-
Carbofuran-induced acute pancreatitisRizos, E.; Liberopoulos, E.; Kosta, P.; Efremidis, S.; Elisaf, M. S.24-Nov-2015-
Changes in serum lipids, lipoproteins and apolipoproteins in patients with acute infectionLiberopoulos, E.; Pappas, G.; Alexandridis, G.; Tsiara, S.; Milionis, H.; Bairaktari, E.; Tsianos, E.; Elisaf, M. S.24-Nov-2015-
Co-trimoxazole-induced hypouricemiaLiberopoulos, E.; Elisaf, M. S.24-Nov-2015-
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and goutLiberopoulos, E.; Christides, D.; Elisaf, M. S.24-Nov-2015-
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistanceMoutzouri, E.; Liberopoulos, E.; Mikhailidis, D. P.; Kostapanos, M. S.; Kei, A. A.; Milionis, H.; Elisaf, M. S.24-Nov-2015-
Comparison of the efficacy of atorvastatin and micronised fenofibrate in the treatment of mixed hyperlipidemiaMiltiadous, G.; Bairaktari, E.; Tzallas, C.; Tsimihodimos, V.; Liberopoulos, E.; Millionis, H.; Rizos, E.; Elisaf, M. S.24-Nov-2015-
Effect of fluvastatin on plasma fibrinogen levelsLiberopoulos, E.; Tsimihodimos, V.; Bairaktari, E.; Tzallas, C.; Rizos, E.; Katsaraki, A.; Miltiadous, G.; Elisaf, M. S.24-Nov-2015-
The Effect of Nicotinic Acid/Laropiprant Administration on the Lipoprotein-Associated Phospholipase A2 (Lp-Pla2) Activity in Patients with Mixed DyslipidemiaKei, A.; Liberopoulos, E.; Tellis, K.; Rizos, C.; Tselepis, A.; Elisaf, M.24-Nov-2015-
The effect of tamoxifen therapy on serum apolipoprotein A-I level is modified by the apolipoprotein E phenotypeLiberopoulos, E.; Pavlidis, N.; Elisaf, M. S.24-Nov-2015-
The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamideAchimastos, A.; Liberopoulos, E.; Nikas, S.; Bairaktari, E.; Miltiadous, G.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-